News
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback